A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
Prescient Therapeutics, Ltd.
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Instituto de Investigación Biomédica de Salamanca
Lund University Hospital
Ohio State University Comprehensive Cancer Center
University College, London
Innate Pharma
Assistance Publique - Hôpitaux de Paris
4SC AG
Emory University
Peking University First Hospital
Columbia University
Kyowa Kirin Co., Ltd.
Northwestern University
City of Hope Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
Wake Forest University Health Sciences
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
Genmab
Stanford University
Genmab
Atara Biotherapeutics
Elorac, Inc.
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Fundación Academia Española de Dermatología
4SC AG
Rutgers, The State University of New Jersey